Achieving the Promise of Personalized Medicine
Author:
- 1 October 2012
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 92 (4) , 401-405
Abstract
Individualized therapy is the practice of tailoring therapeutic intervention to a patient's disease, demographic characteristics, genetics, environment, lifestyle, and health status. In addition to previous methods of individualization, individualization based on pharmacogenomics is an emerging practice. Although tools are available to aid the determination of the need to individualize therapy, there are barriers to implementation. Various institutions have instituted programs to demonstrate the benefit of individualization, including programs that involve preemptive genotyping.Keywords
This publication has 5 references indexed in Scilit:
- Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive GenotypingClinical Pharmacology & Therapeutics, 2012
- Pharmacogenetics — Tailoring Treatment for the OutliersNew England Journal of Medicine, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Metabolomics-Based Systems Biology and Personalized Medicine: Moving Towards n = 1 Clinical Trials?Pharmacogenomics, 2006
- Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene LocusJNCI: Journal of the National Cancer Institute, 1999